Sponsored Links
Lymphoma Information Network » Lymphoma Info » Older Lymphoma Classification and Typing Schemes

Older Lymphoma Classification and Typing Schemes

classification montage

There are many types of lymphoma, all classified based on their cell type, cell markers, location of the cancerous mutation, and how they grow. However, the classification systems have changed and evolved over the years as scientists and doctors learn more about the disease.

The different systems used are the Rappaport System, Kiel System, Working Formulation, Revised European-American Classification of Lymphoid Neoplasms (REAL), and the World Health Organization (WHO) Sytem.

WHO Classification

The WHO International Classification of Diseases was first published 1893. The ICD is the international standard diagnostic classification and we regard it as the best current model. Please visit our Lymphoma Classification page for more details.

The Rappaport System

This system was used until the mid 1970's. The classification system divides cells into three categories based on cell differentiation. Cell differentiation is the process in which immature cells become specialized, mature cells. The categories were:

  • Well differentiated cells, or small lymphocytic lymphoma
  • Poorly differentiated cells, or follicular and small cleaved lymphomas
  • Histiocytic cells, or large cell lymphomas
  • It was created prior to the distinction between B-cells and T-cells, and is now rarely used. The only way to tell the cell types apart was by looking under a microscope, and the updated tissue tests available nowadays can categorize cancerous cells much better.

The Kiel System

The Kiel System was popular in Europe and was introduced in 1974. It was based on immunologic tests that identified the proteins that cancer cells made. In the United States, a similar system, called the Lukes and Collins Classification, was the first to classify based on B-cell and T-cell types.

National Cancer Institute's Working Formulation (IWF)

This system was introduced in the 1980's and classified cells based on cell differentiation, cell size, and whether or not the cell was cleaved. This led to the distinction between low-grade and high-grade cancers.

Small lymphocytic lymphoma, follicular small-cleaved cell lymphoma, and follicular mixed small-cleaved and large cell lymphomas were all considered low grade.

Diffuse small cleaved cell, diffuse mixed small and large cell, diffuse large cell, and follicular large cell lymphoma were all considered intermediate grade.

Lymphoblastic, small non-cleaved cell, and large cell immunoblastic lymphomas were all considered high grade.

REAL Classification

These classification systems were revised in the 1990's by the International Lymphoma Study Group. They compiled a consensus of lymphomas in order to study and classify them. This system became the basis of the WHO system in place today.

Sponsored Links

Cancer Support Groups

SupportGroups.com aims to build awareness and provide support for Hodgkin's Lymphoma and Non-Hodgkin's Lymphoma. If you are a friend or parent of a person that has been diagnosed with Lymphoma, or you have been diagnosed with Lymphoma, you are not alone. Share personal experiences, evaluate information and get support during times of need, illness, treatment or recovery.

Dive Deeper

disclaimer

The information provided on the Lymphoma Information Network is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her health professional. This information is solely for informational and educational purposes. The publication of this information does not constitute the practice of medicine, and this information does not replace the advice of your physician or other health care provider. Neither the owners or employees of LymphomaInfo.net nor the author(s) of site content take responsibility for any possible consequences from any treatment, procedure, exercise, dietary modification, action or application of medication which results from reading this site. Always speak with your primary health care provider before engaging in any form of self treatment. Please see our Legal Statement for further information.

Featured Treatment
searching for treatment

Featured Treatment: Zevalin®

Zevalin® (Ibritumomab tiuxetan) is a form of radioimmunotherapy (a radiolabeled monoclonal antibody) for treatment of patients with relapsed or refractory, low‑grade or follicular B‑cell non‑Hodgkin's lymphoma (NHL). "Refractory" refers to a disease that does not respond to treatment.

Zevalin is the first radioummunotherapy treatment to be FDA-approved as a first-line therapy for lymphoma. Read more...

Sponsored Links
User login
Cancer Support Groups

Cancer Support Groups

support groups

SupportGroups.com aims to build awareness and provide support for Hodgkin's Lymphoma and Non-Hodgkin's Lymphoma. If you are a friend or parent of a person that has been diagnosed with Lymphoma, or you have been diagnosed with Lymphoma, you are not alone. Share personal experiences, evaluate information and get support during times of need, illness, treatment or recovery.

Poll
What is most important to you in an Online Support Group?:
Latest Blog Entries

Did You Know?
Since the early 1970s, incidence rates for non-Hodgkin’s lymphoma have nearly doubled. Incidence rates for Hodgkin’s disease have declined about 60%. Better means of diagnosis has also increased the number as doctors better understand cancer of lymphocytes verses other diseases.